Why the study?
Does pipecuronium improve haemodynamic stability compared to pancuronium in patients undergoing coronary artery bypass grafting?
Does pipecuronium improve haemodynamic stability compared to pancuronium in patients undergoing coronary artery bypass grafting?
Pipecuronium offers better haemodynamic stability than pancuronium during fentanyl anaesthesia for CABG, making it advantageous for patients with cardiovascular disease.
Pipecuronium may preserve haemodynamic stability better than pancuronium in fentanyl-anesthetized CABG; Level 5 data leaves open need for randomized trials.
Haemodynamic variables were measured following administration of pipecuronium 70 micrograms.kg-1 and pancuronium 90 micrograms.kg-1 (approximately equivalent to 1.5 x ED95) in patients anaesthetised with fentanyl 50 micrograms.kg-1 and scheduled to undergo coronary artery bypass grafting. There were significant increases in heart rate (22%), mean arterial pressure (10%), cardiac index (16%), and the rate pressure product (35%) following administration of pancuronium. The absolute values of these parameters were, however, within acceptable clinical limits. Administration of pipecuronium produced minimal and insignificant changes in these parameters. Other measured or derived indices showed only small changes with both agents and these were generally insignificant. There were no incidences of significant bradycardia following pipecuronium administration. The results from the present study suggest that pipecuronium would have advantages for use in patients with significant cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Stanley et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: